Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Cell|November 20, 2018
Secretin-Activated Brown Fat Mediates Prandial Thermogenesis to Induce SatiationYongguo Li, Katharina Schnabl, Sarah-Madeleine Gabler, et al.Diabetes|November 7, 2023
GIPR Agonism Enhances TZD-Induced Insulin Sensitivity in Obese IR MiceEllen C Furber, Karissa Hyatt, Kyla Collins, et al.Diabetes|April 24, 2019
Modified UCN2 Peptide Acts as an Insulin Sensitizer in Skeletal Muscle of Obese MiceMelissa L Borg, Julie Massart, Milena Schönke, et al.EMBO Molecular Medicine|January 19, 2018
The GPR120 agonist TUG-891 promotes metabolic health by stimulating mitochondrial respiration in brown fatMaaike Schilperoort, Andrea D van Dam, Geerte Hoeke, et al.Molecular Metabolism|October 18, 2025
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of conceptDaniel A Briere, Hongchang Qu, Katherine Lansu, et al.Cell Metabolism|August 19, 2022
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of conceptTamer Coskun, Shweta Urva, William C Roell, et al.Frontiers in Physiology|January 29, 2019
High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose TissueEline N Kuipers, Vasudev Kantae, Boukje C Eveleens Maarse, et al.Diabetes, Obesity & Metabolism|January 9, 2026
GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian modelsCaitlin Baumer-Harrison, Danya Aldaghma, Alex D White, et al.Kidney International|April 26, 2026
Reversal of advanced diabetic kidney disease in mice treated with a monoclonal anti-VEGFR1 antibodyZhonghua Qi, Ying Tang, Johnny Eugene Croy, et al.Journal of Clinical Lipidology|June 20, 2017
Short-term cooling increases serum triglycerides and small high-density lipoprotein levels in humansGeerte Hoeke, Kimberly J Nahon, Leontine E H Bakker, et al.Pageof 10